Ribavirin interferon acyclovir treatment of children with triple therapy efficacy of viral encephalitis_0.docVIP

 PAGE \* MERGEFORMAT 11 Ribavirin interferon acyclovir treatment of children with triple therapy efficacy of viral encephalitis [Abstract] Objective To observe ribavirin, interferon, antiviral Acyclovir method the efficacy of viral encephalitis in children. Methods 72 patients with viral encephalitis were randomly divided into combined group (n = 28) and single group (n = 44), United were given ribavirin 10 ~ 15mg/kg d + acyclovir 10mg/kg d + interferon IFN 2-Ib 10 ~ 2 0 U; single treatment group ribavirin alone 10 ~ 15mg/kg d. After treatment, symptoms and signs disappeared observation time, the recovery of laboratory tests and adverse reactions. The results of time two groups of children with symptoms including fever 3.24 + -0.65 vs 4.32 + - 0.87, convulsions 2.36 + -0.38 vs 4.65 + -0.87, headache 3.18 + -0.68 vs 5.34 + -0.87, vomiting 2.66 + -0.39 vs 4.66 + -0.97, consciousness 3.56 + -0.54 vs 5.82 + -0.91, meningeal irritation 3.91 + -0.48 vs 5.37 + -1.69, compared the two groups, the joint group of symptoms than a single group was significantly shorter, P lt;0.05; white blood cell count returned to normal rate in the combination group (90%) than a single group (73.3% ) was significantly higher, P lt;0.05, normal cerebrospinal fluid ratio of conventional combination group (100%) than a single group (88.2%) were significantly increased. two rates of adverse reactions was no difference appears. Conclusion of ribavirin, interferon and A Xi Lowe comprehensive treatment of children with triple therapy can reduce viral encephalitis in children with symptoms and signs of regression time, and no significant adverse reactions. [Keywords:] ribavirin; interferon; acyclovir; viral encephalitis, in children Abstract Objective To observe the curative effects of combined ribovirin, interferon and acyclovir in treating child viral encephalitis.Methods 72 children with viral encephalitis were randomly divided into 2 groups, 1 combined treatment group (n = 28) a